Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,783 | -130,149 | -85,765 | -46,426 | -11,655 |
| Depreciation Amortization | -179 | -4,355 | -3,740 | -3,660 | -1,481 |
| Accounts receivable | -53,542 | 164,879 | 164,417 | 165,000 | 165,000 |
| Accounts payable and accrued liabilities | 3,003 | 3,723 | 4,030 | 1,612 | 1,237 |
| Other Working Capital | -67,064 | 146,209 | 148,874 | 120,813 | 124,692 |
| Other Operating Activity | 65,056 | -122,636 | -133,170 | -140,756 | -152,430 |
| Operating Cash Flow | $-48,943 | $57,671 | $94,646 | $96,583 | $125,363 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -215 | -1,590 | -1,446 | -1,358 | -545 |
| Purchase Of Investment | -68,968 | -546,585 | -442,311 | -281,194 | -214,040 |
| Sale Of Investment | 160,075 | 498,843 | 345,610 | 242,960 | 120,183 |
| Investing Cash Flow | $90,892 | $-49,332 | $-98,147 | $-39,592 | $-94,402 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,374 | 23,343 | 20,506 | 14,847 | 11,922 |
| Other Financing Activity | 0 | -479 | -479 | -479 | -479 |
| Financing Cash Flow | $23,374 | $22,864 | $20,027 | $14,368 | $11,443 |
| Beginning Cash Position | 128,677 | 97,474 | 97,474 | 97,474 | 97,474 |
| End Cash Position | 194,000 | 128,677 | 114,000 | 168,833 | 139,878 |
| Net Cash Flow | $65,323 | $31,203 | $16,526 | $71,359 | $42,404 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,943 | 57,671 | 94,646 | 96,583 | 125,363 |
| Capital Expenditure | -215 | -1,590 | -1,446 | -1,358 | -545 |
| Free Cash Flow | -49,158 | 56,081 | 93,200 | 95,225 | 124,818 |